0 CHECKOUT

PRODUCT FILTERS

REGION

CATEGORIES

  • 6
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

0
1
2
42

PUBLISHED

0
11
30
42

PRODUCT TYPE

42

Search for: "Biomedica International-Therapeutic Competitors Report"

Competitor Analysis: Cancer Vaccines

The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines to fight cancer as of March 2014 Purchase...

Published:  March 2014
Price:  From

Cancer Vaccines Markets

Cancer vaccines have the potential to become a significant force in future cancer treatments In 2010, Dendreon's Provenge became the first cancer vaccine approved by the FDA, generating renewed interest...

Published:  May 2011
Price:  From

Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2015

Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2015 Summary The report ‘Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2015’, provides an overview of the Amyotrophic Lateral Sclerosis’s...

Published:  December 2015
Price:  From

Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2015

Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2015 Summary the, ‘Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2015’, provides an overview of the Amyotrophic Lateral Sclerosis’s therapeutic...

Published:  June 2015
Price:  From

Malignant Mesothelioma - Pipeline Review, H1 2015

Malignant Mesothelioma - Pipeline Review, H1 2015 Summary This, ‘Malignant Mesothelioma - Pipeline Review, H1 2015’, provides an overview of the Malignant Mesothelioma’s therapeutic pipeline. This...

Published:  May 2015
Price:  From

Epithelial Ovarian Cancer - Pipeline Review, H1 2015

Epithelial Ovarian Cancer - Pipeline Review, H1 2015 Summary This, ‘Epithelial Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Epithelial Ovarian Cancer’s therapeutic pipeline. This...

Published:  May 2015
Price:  From

Glaucoma - Pipeline Review, H2 2015

Glaucoma - Pipeline Review, H2 2015 Summary The report ‘Glaucoma - Pipeline Review, H2 2015’, provides an overview of the Glaucoma’s therapeutic pipeline. This report provides comprehensive information...

Published:  December 2015
Price:  From

Liver Fibrosis - Pipeline Review, H2 2015

Liver Fibrosis - Pipeline Review, H2 2015 Summary The report ‘Liver Fibrosis - Pipeline Review, H2 2015’, provides an overview of the Liver Fibrosis’s therapeutic pipeline. This report provides comprehensive...

Published:  October 2015
Price:  From

Malignant Pleural Mesothelioma - Pipeline Review, H1 2015

Malignant Pleural Mesothelioma - Pipeline Review, H1 2015 Summary This, ‘Malignant Pleural Mesothelioma - Pipeline Review, H1 2015’, provides an overview of the Malignant Pleural Mesothelioma’s therapeutic...

Published:  May 2015
Price:  From

Glaucoma - Pipeline Review, H1 2015

Glaucoma - Pipeline Review, H1 2015 Summary This, ‘Glaucoma - Pipeline Review, H1 2015’, provides an overview of the Glaucoma’s therapeutic pipeline. This report provides comprehensive information...

Published:  January 2015
Price:  From

Liver Fibrosis - Pipeline Review, H1 2015

Liver Fibrosis - Pipeline Review, H1 2015 Summary This, ‘Liver fibrosis - Pipeline Review, H1 2015’, provides an overview of the Liver fibrosis’s therapeutic pipeline. This report provides comprehensive...

Published:  February 2015
Price:  From

Ischemic Stroke - Pipeline Review, H1 2015

Ischemic Stroke - Pipeline Review, H1 2015 Summary: This, ‘Ischemic Stroke - Pipeline Review, H1 2015’, provides an overview of the Ischemic Stroke’s therapeutic pipeline. This report provides...

Published:  March 2015
Price:  From

Parkinson's Disease - Pipeline Review, H2 2015

Parkinson's Disease - Pipeline Review, H2 2015 Summary The report ‘Parkinson's Disease - Pipeline Review, H2 2015’, provides an overview of the Parkinson's Disease’s therapeutic pipeline. This report...

Published:  December 2015
Price:  From

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015 Summary This, ‘Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer...

Published:  January 2015
Price:  From

Myocardial Infarction - Pipeline Review, H2 2015

Myocardial Infarction - Pipeline Review, H2 2015 Summary The report ‘Myocardial Infarction - Pipeline Review, H2 2015’, provides an overview of the Myocardial Infarction’s therapeutic pipeline. This...

Published:  September 2015
Price:  From

Myocardial Infarction - Pipeline Review, H1 2015

Myocardial Infarction - Pipeline Review, H1 2015 Summary: This, ‘Myocardial Infarction - Pipeline Review, H1 2015’, provides an overview of the Myocardial Infarction’s therapeutic pipeline. This...

Published:  March 2015
Price:  From

Parkinson's Disease - Pipeline Review, H1 2015

Parkinson's Disease - Pipeline Review, H1 2015 Summary the, ‘Parkinson's Disease - Pipeline Review, H1 2015’, provides an overview of the Parkinson's Disease’s therapeutic pipeline. This report provides...

Published:  June 2015
Price:  From

Sepsis - Pipeline Review, H1 2015

Sepsis - Pipeline Review, H1 2015 Summary: This, ‘Sepsis - Pipeline Review, H1 2015’, provides an overview of the Sepsis’s therapeutic pipeline. This report provides comprehensive information...

Published:  March 2015
Price:  From

Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019

Global Market Watch: Global Regenerative Medicine market is estimated to reach US$24.7 billion by 2017. Regenerative Medicine in Orthopedics market is projected to reach US$10.3 billion by 2017,...

Published:  April 2015
Price:  From

Dendritic Cell and CAR-T Therapies, 2014 - 2024

The focus of drug developers is gradually moving towards immunotherapeutics, which make use of the body’s own immune system or its components to fight cancer. It is a relatively new concept, with the...

Published:  November 2014
Price:  From
Loading Indicator

Our Clients

  • Intel Corporation
  • Autodesk, Inc.
  • Hewlett-Packard Company
  • Ahlstrom Corporation
  • SAP SE
  • 3M Company
  • Samsung Group Ltd.